 The main purpose of this project is to evaluate the efficiency of the injection of CD4 and CD8 T cell anti-Cytomegalovirus CMV on blood viral replication of CMV, 21 days after the first injection adenovirus infection is not enough usual, especially in adults, to be used for the primary purpose and is measured in the secondary endpoints. 